Study maps immune responses produced by COVID-19 vaccination in First Nations population

Published in Nature Immunology and Nature Briefing, the research is the first of its kind to decisively map immune responses produced by a COVID-19 vaccination in any First Nations populations.

In partnership with Menzies School of Health Research, researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) evaluated immune responses in Aboriginal and Torres Strait Islander peoples and non-Indigenous individuals after receiving the mRNA COVID-19 vaccine.

Lead author of the study and PhD candidate at the Doherty Institute, University of Melbourne's Wuji Zhang, said the research provides strong evidence that COVID-19 vaccination triggers effective immune responses against the virus in First Nations peoples.

"We found excellent antibody and T cell responses against SARS-CoV-2 in Australian First Nations peoples following COVID-19 vaccination. We saw high levels of antibodies binding to the virus following two vaccine doses," Mr Zhang said.

"T cells against the spike protein, which often recognize small sections of the virus and are similar across different variants, were also seen in higher numbers and showed 'memory signatures' following vaccination."

University of Melbourne Professor Katherine Kedzierska, a Laboratory Head at the Doherty Institute, said the findings are the first to report excellent immune responses to COVID-19 vaccination in First Nations peoples.

"Like other studies on non-Indigenous cohorts, antibody responses against the COVID variants Delta and Omicron were lower compared to the ancestral strain, but were substantially increased following the booster vaccine dose.

While the results of the study are encouraging, it also showed that antibody responses are highly affected by comorbidities in Indigenous populations, especially diabetes and renal disease."

Professor Katherine Kedzierska, University of Melbourne

Associate Professor Jane Davies of Menzies School of Health Research said the results confirm the effectiveness of vaccination.

"Our research should further encourage First Nations communities around the world to get vaccinated and boosted," Associate Professor Davies said.

"This work also highlights the crucial importance of being up-to-date with COVID vaccination for individuals with comorbidities, especially diabetes and renal disease."

Source:
Journal reference:

Zhang, W., et al. (2023). Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities. Nature Immunology. doi.org/10.1038/s41590-023-01508-y.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine shows potential in preventing recurrence of triple-negative breast cancer